DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Barf T, Covey T, Izumi R. , et al.
Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile.

J Pharmacol Exp Ther 2017;
363 (02) 240-252

Barf T, Covey T, Izumi R. , et al.
Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile.

J Pharmacol Exp Ther 2017;
363 (02) 240-252

Download Bibliographical Data

Search in:
Access: